ClinVar Miner

Submissions for variant NM_003242.6(TGFBR2):c.1159G>T (p.Val387Leu)

dbSNP: rs35766612
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000152009 SCV000053215 benign not specified 2021-07-27 criteria provided, single submitter clinical testing Variant summary: TGFBR2 c.1159G>T (p.Val387Leu) results in a conservative amino acid change located in the Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00035 in 250480 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 112-fold of the estimated maximal expected allele frequency for a pathogenic variant in TGFBR2 causing Loeys-Dietz Syndrome phenotype (3.1e-06), strongly suggesting that the variant is benign. p.Val387Leu has been reported in the literature in individuals affected with Marfan Syndrome (MFS), Loeys-Dietz Syndrome (LDS) or Thoracic Aortic Aneurysms and Dissections (TAAD) (Matyas_2006, Stheneur_2008, Lerner-Ellis_2014), while it was also reported in a case of Brain arteriovenous malformation (Scimone_2020). Two of these studies reported the variant as likely benign or polymorphism. These reports do not provide unequivocal conclusions about association of the variant with Loeys-Dietz Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign and two ClinVar submitters (evaluation after 2014) cite it as uncertain significance. Based on the evidence outlined above, the variant was classified as benign.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000152009 SCV000200575 likely benign not specified 2010-08-20 criteria provided, single submitter clinical testing
GeneDx RCV001703428 SCV000250936 likely benign not provided 2020-09-09 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 18781618, 16791849, 17061023, 24793577)
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia RCV000030544 SCV000296973 uncertain significance Loeys-Dietz syndrome 2015-09-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV000249454 SCV000319271 likely benign Familial thoracic aortic aneurysm and aortic dissection 2019-09-19 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV000414949 SCV000492956 uncertain significance Ascending tubular aorta aneurysm; Vascular dilatation 2014-05-27 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000249454 SCV000548116 benign Familial thoracic aortic aneurysm and aortic dissection 2024-01-26 criteria provided, single submitter clinical testing
Center for Human Genetics, Inc, Center for Human Genetics, Inc RCV000249454 SCV000782369 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2016-11-01 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000249454 SCV000903193 likely benign Familial thoracic aortic aneurysm and aortic dissection 2018-05-07 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002277109 SCV002566151 uncertain significance Ehlers-Danlos syndrome 2020-02-01 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000249454 SCV003838805 benign Familial thoracic aortic aneurysm and aortic dissection 2021-08-20 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004754278 SCV005362568 likely benign TGFBR2-related disorder 2024-04-18 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.